Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques

Sponsor
Mayo Clinic (Other)
Overall Status
Recruiting
CT.gov ID
NCT02548546
Collaborator
(none)
30
1
3
84
0.4

Study Details

Study Description

Brief Summary

The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta.

Condition or Disease Intervention/Treatment Phase
  • Device: ECHO
  • Device: ECG-gated MRA
N/A

Detailed Description

Patients with Abdominal Aortic Aneurysm, (AAA), will be identified within the vascular surgery practice. Those patients who meet standard indications for surgery including symptomatic AAA, size >5.0-5.5 cm, or rapidly enlarging >0.5 cm per 6 months will have standard pre-operative work-up which includes magnetic resonance angiogram (MRA) and Echocardiogram (ECHO). These pre-operative studies will be modified for the study patients to include electrocardiogram(ECG)-gating (coupled with MR angiogram) and 2-Dimensional speckle-tracking ultrasound of the abdominal aorta. Patients in the study will be followed for 1 year. Measurements will be analyzed for any relationship between aortic wall properties and clinical outcomes such as aneurysm growth, rupture risk or aortic dissection. This study will be comparing 3 groups of patients: no surgery (surveillance), open surgery, and endovascular aneurysm repair (EVAR).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
Study Start Date :
Aug 1, 2015
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Surveillance

No Surgery with ECHO and ECG-gated MRA imaging.

Device: ECHO
Imaging

Device: ECG-gated MRA
Imaging

Active Comparator: Surgery-Open

Open Surgery with ECHO and ECG-gated MRA imaging.

Device: ECHO
Imaging

Device: ECG-gated MRA
Imaging

Active Comparator: Surgery-EVAR

EVAR with ECHO and ECG-gated MRA imaging.

Device: ECHO
Imaging

Device: ECG-gated MRA
Imaging

Outcome Measures

Primary Outcome Measures

  1. ECHO Imaging [Change from baseline in ECHO imaging measurements]

    Imaging taken of the aneurysm, locating peak wall stress and measuring percent of strain per seconds.

Secondary Outcome Measures

  1. ECG-gated MRA Imaging [Change from baseline ECG-gated imaging measurements.]

    The MRA imaging will be taken with the ECG-gating to synchronize the timing of the image acquisition with cardiac motion. This will allow for more accurate measurement of vessel diameter measured in mm (millimeters) and reported in percent change from baseline.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients >18 years of age with ability to provide informed consent.

  • Patients with either symptomatic or asymptomatic AAA as defined by aortic diameter ≥ 1.5x normal diameter.

  • Patients with non-aneurysmal aortas who require aortic contrast imaging or echocardiography for preoperative planning or other reason.

Exclusion Criteria:
  • Patients with contraindication to IV contrast such as allergy or severe kidney dysfunction.

  • Patients who do not require contrast imaging or echocardiogram as part of their care plan.

  • Terminally ill patients, and patients with estimated life expectancy of ≤ 6 months.

  • Patients unable to tolerate magnetic resonance imaging.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Florida Jacksonville Florida United States 32224

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Houssam Farres, MD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Houssam Farres, M.D., PI, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT02548546
Other Study ID Numbers:
  • 14-004151
First Posted:
Sep 14, 2015
Last Update Posted:
Oct 5, 2021
Last Verified:
Oct 1, 2021
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2021